PeptiDream Inc. | Ownership
Companies that own PeptiDream Inc.
J.O. Hambro Capital Management Ltd.
8,018,422
6.53%
-714,678
1.14%
03/30/2018
JPMorgan Asset Management (Japan) Ltd.
5,066,700
4.13%
123,300
1.46%
08/15/2018
Asset Management One Co., Ltd.
5,044,600
4.11%
194,400
0.14%
03/30/2018
OppenheimerFunds, Inc.
3,000,000
2.44%
2,000,000
0.07%
03/31/2018
Nomura Asset Management Co., Ltd.
2,886,998
2.35%
641,399
0.06%
07/31/2018
Shiozumi Asset Management Co. Ltd.
2,100,000
1.71%
-70,000
5.67%
07/31/2018
Baillie Gifford & Co.
2,085,700
1.7%
81,400
0.05%
04/30/2018
The Vanguard Group, Inc.
1,994,560
1.62%
39,200
0%
07/31/2018
Matthews International Capital Management LLC
1,834,600
1.49%
23,100
0.23%
06/30/2018
Invesco Asset Management (Japan) Ltd.
1,251,494
1.02%
443,112
1.11%
03/29/2018
| Address |
3-25-23 Tonomachi
Kawasaki Kanagawa 210
Japan
|
|
Employees
|
- |
| Website |
http://www.peptidream.com |
| Updated |
07/08/2019 |
| PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan. |
